Results 131 to 140 of about 126,669 (262)

Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection [PDF]

, 2005
Luuk B. Hilbrands, Andries J. Hoitsma, Jack F.M. Wetzels   +2 more
openalex   +3 more sources

Atrial Electrical Remodeling in Mice With Cardiac-Specific Overexpression of Angiotensin II Type 1 Receptor. [PDF]

J Am Heart Assoc, 2022
Demers J, Ton AT, Huynh F, Thibault S, Ducharme A, Paradis P, Nemer M, Fiset C.   +7 more
europepmc   +1 more source

Angiotensin II Type 1 Receptor Blockers Do Not Promote Coronary Collateral Circulation in Patients with Coronary Artery Disease [PDF]

, 2006
Satoshi Imaizumi, Shin-ichiro Miura, Hiroaki Nishikawa, Atsushi Iwata, Bo Zhang, Akira Kawamura, Yoshihiro Tsuchiya, Koichiro Kumagai, Keitaro Matsuo, Keijiro Saku   +9 more
openalex   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Angiotensin II type 1 receptor localizes at the blood-bile barrier in humans and pigs. [PDF]

Histochem Cell Biol, 2022
Pryymachuk G, El-Awaad E, Piekarek N, Drebber U, Maul AC, Hescheler J, Wodarz A, Pfitzer G, Neiss WF, Pietsch M, Schroeter MM.   +10 more
europepmc   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Zinc Complexation Improves Angiotensin II Receptor Type 1 Blockade and In Vivo Antihypertensive Activity of Telmisartan

, 2020
Valeria R. Martínez, María Victoria Aguirre, Juan Santiago Todaro, Augusto Martins Lima, Nikolaos Stergiopulos, Evelina G. Ferrer, Patricia A.M. Williams   +6 more
openalex   +2 more sources

Systemic sclerosis as prototypic disease with high levels of functional antibodies against angiotensin II type-1 and endothelin-1 type A receptor strongly predicting prognosis [PDF]

, 2010
Gabriela Riemekasten, Aurélie Philippe, Ivo Lukitsch, Torsten Slowinski, Melanie Näther   +4 more
openalex   +1 more source

Analysis of the usefulness and benefits of ultrafiltration in cardiorenal syndrome: A systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 1194-1202, April 2025.
Abstract Aims Cardiac decompensation in cardiorenal syndrome (CRS) results in systemic congestion usually treated with diuretics. When despite high doses of diuretics, response is poor, ultrafiltration (UF) appears to be a useful and safe technique.
Borja Guerrero Cervera, Raquel López‐Vilella, Víctor Donoso Trenado, María Peris‐Fernández, Paula Carmona, Amparo Soldevila, Sergi Tormo, Ramón Devesa, María Jesús Montero Hernández, Luis Martínez Dolz, Julio Hernández Jaras, Pilar Sánchez‐Pérez, Luis Almenar‐Bonet   +12 more
wiley   +1 more source

Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin-Deficient Mice via Upregulation of Angiotensin (1-7). [PDF]

J Am Heart Assoc, 2023
Karasaki K, Kokubo H, Bumdelger B, Kaji N, Sakai C, Ishida M, Yoshizumi M.   +6 more
europepmc   +1 more source